Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancer

od Yap, Timothy A, Popat, Sanjay
Izdano 2014

Development of Molecularly Driven Targeted Combination Strategies

od Yap, Timothy A., Rodon, Jordi
izdano v Oncologist (2017)

c-MET: an exciting new target for anticancer therapy

od de Bono, Johann S., Yap, Timothy A.
Izdano 2011

Future directions in the evaluation of c-MET-driven malignancies

od de Bono, Johann S., Yap, Timothy A.
Izdano 2011

Combination drug development in BRAF mutant colorectal cancer

od Lam, Michael, Pant, Shubham, Yap, Timothy A.
izdano v Oncoscience (2018)

Personalization of prostate cancer prevention and therapy: are clinically qualified biomarkers in the horizon?

od Yap, Timothy A, Swanton, Charles, de Bono, Johann S
Izdano 2012

Strategies for modern biomarker and drug development in oncology

od Smith, Alan D, Roda, Desam, Yap, Timothy A
Izdano 2014

PARP inhibitors: the race is on

od Brown, Jessica S, Kaye, Stan B, Yap, Timothy A
izdano v Br J Cancer (2016)

Emerging strategies for the treatment of advanced small cell lung cancer

od Lim, Joline S. J., Collins, Dearbhaile, Yap, Timothy A.
izdano v J Thorac Dis (2016)

Precision Medicine for Molecularly Targeted Agents and Immunotherapies in Early-Phase Clinical Trials

od Lopez, Juanita, Harris, Sam, Roda, Desam, Yap, Timothy A
izdano v Transl Oncogenomics (2015)

Targeting BRAF Mutant Colorectal Cancer: Progress in Combination Strategies

od Sundar, Raghav, Hong, David S, Kopetz, Scott, Yap, Timothy A
izdano v Cancer Discov (2017)

Global Implementation of Precision Oncology

od Yam, Clinton, Ma, Brigette B. Y., Yap, Timothy A.
izdano v JCO Precis Oncol (2021)

Targeting the PI3K-AKT-mTOR signaling network in cancer

od Khan, Khurum H., Yap, Timothy A., Yan, Li, Cunningham, David
Izdano 2013

Drugging PI3K in cancer: refining targets and therapeutic strategies

od Yap, Timothy A, Bjerke, Lynn, Clarke, Paul A, Workman, Paul
izdano v Curr Opin Pharmacol (2015)

Immuno-oncology combinations: raising the tail of the survival curve

od Harris, Samuel J., Brown, Jessica, Lopez, Juanita, Yap, Timothy A.
izdano v Cancer Biol Med (2016)

The role of Schlafen 11 (SLFN11) as a predictive biomarker for targeting the DNA damage response

od Coleman, Niamh, Zhang, Bingnan, Byers, Lauren A., Yap, Timothy A.
izdano v Br J Cancer (2020)

Combining targeted therapeutics in the era of precision medicine

od Papadatos-Pastos, D, De Miguel Luken, M J, Yap, Timothy A
izdano v Br J Cancer (2015)

Targeting DNA Repair in Cancer: Beyond PARP Inhibitors

od Brown, Jessica S., O’Carrigan, Brent, Jackson, Stephen P., Yap, Timothy A.
izdano v Cancer Discov (2016)

Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer

od Sundar, Raghav, Chénard-Poirier, Maxime, Collins, Dearbhaile Catherine, Yap, Timothy A.
izdano v Front Med (Lausanne) (2017)

Shotgun: A Bayesian seamless phase I-II design to accelerate the development of targeted therapies and immunotherapy

od Jiang, Liyun, Li, Ruobing, Yan, Fangrong, Yap, Timothy A., Yuan, Ying
izdano v Contemp Clin Trials (2021)